Notice of meeting - 2026 Combined General Shareholder's Meeting

BIOGRAPHY

Thomas H. Glocer was a corporate lawyer at the Davis Polk & Wardwell law firm, before joining Reuters in 1993. He was appointed CEO of Reuters Group in 2001 and then from April 2008 to December 2011, CEO of Thomson Reuters Corp.

He is currently Executive Chair of the Board of BlueVoyant Inc and Chair of the Board of Istari Global Ltd, companies specialized in cyber defense, and Executive Chair of the Board of Capitolis Inc., specialized in financial technology. He is also General Partner at Communitas Capital LLC, a venture capital company, and member of the Boards of Directors of Morgan Stanley, Merck & Co and System Inc.

Other offices and positions held within the Groupe

None

Main offices and positions held outside the Groupe

• Founder and Managing Partner: Angelic Ventures LP (United States)
• Executive Chair of the Board: Capitolis, Inc. (United States), BlueVoyant Inc. (United States)
• Chair of the Board: Istari Global Ltd (United Kingdom)
• General Partner: Communitas Capital LLC (United States)
• Director: Merck & Co., Inc., listed company (United States), Morgan Stanley, listed company (United States), K2 Integrity, Inc. (United States), Atlantic Council (United States), System Inc. (United States), International Tennis Hall of Fame (United States)
• Member of the Board of Trustees: Cleveland Clinic (United States)
• Member: President’s Council on International Activities at Yale University (United States), European Business Leaders Coun-cil – EBLC (Finland)
• Member of the Advisory Committee: Columbia Global Center, Paris (United States)
• Mentor: CMI (United Kingdom)
• Adviser: Norm AI (United States)

Offices held outside the Groupe in the last five years

Offices listed above as well as the following offices:

• Member of the International Advisory Group: Linklaters LLP (United Kingdom) (term ended in 2023)
• Director: Reynen Court LLC (United States) (term ended in 2022)

Key expertises^*